Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/128620
Título: The Effectiveness of a Single Dry Needling Session on Gait and Quality of Life in Multiple Sclerosis: A Double-Blind Randomized Sham-Controlled Pilot Trial
Autores/as: Javier Ormazabal, Alberto 
González-Platas, Montserrat
Jiménez-Sosa, Alejandro
Herrero, Pablo
Lapuente-Hernández, Diego
Clasificación UNESCO: 32 Ciencias médicas
321311 Fisioterapia
320404 Rehabilitación (médica)
Palabras clave: Dry needling
Gait performance
Multiple sclerosis
Walking capacity
Fecha de publicación: 2024
Publicación seriada: Healthcare 
Resumen: Introduction: Gait disorders are a major cause of disability and reduced health-related quality of life in people with multiple sclerosis (pwMS). Dry needling (DN) has demonstrated positive results to improve gait parameters in patients with stroke. The main aim of this study was to evaluate the effect of a single session of DN in the gait performance of pwMS. Methods: A double-blind parallel randomized sham-controlled pilot trial was conducted. Study participants received a single session of active DN or sham DN in the gastrocnemius medialis muscle. Pre-treatment and immediately post-treatment measurements were taken, as well as at one and four weeks after the intervention. Outcomes related to gait performance (Timed 25-Foot Walk), self-perceived walking capacity (Multiple Sclerosis Walking Scale), risk of falls (Timed Up and Go test), disability level (Expanded Disability Status Score) and quality of life (Multiple Sclerosis Quality of Life-54 questionnaire and Analogic Quality of Life scale) were evaluated. Results: 18 patients who had multiple sclerosis participated in the study. The group who received active DN showed within-group significant statistical differences immediately after treatment for gait performance (p = 0.008) and risk of falls (p = 0.008), as well as for self-perceived walking capacity at one week (p = 0.017) and four weeks (p = 0.011) and quality of life at four weeks (p = 0.014). Regarding the comparison between groups, only significant results were obtained in the physical domain of the quality of life at four weeks (p = 0.014). Conclusions: DN seems to be a promising therapeutic tool for the treatment of gait disorders in pwMS. However, when results were compared with sham DN, no differences were found.
URI: http://hdl.handle.net/10553/128620
ISSN: 2227-9032
DOI: 10.3390/healthcare12010010
Fuente: Healthcare [EISSN 2227-9032],v. 12 (1), (Enero 2024)
Colección:Artículos
Adobe PDF (1,7 MB)
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.